MedPath
TGA Approval

Tezspire, tezepelumab 210 mg in 1.91mL solution for Injection prefilled syringe (427956)

427956

Tezspire, tezepelumab 210 mg in 1.91mL solution for Injection prefilled syringe

AstraZeneca Pty Ltd

March 24, 2025

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/2f57df40534991738662a2c8feb68c4e.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/9d3e37730b6d967e30d71f359485fa96.pdf

Active Ingredients

tezepelumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tezspire, tezepelumab 210 mg in 1.91mL solution for Injection prefilled syringe (427956) - TGA 批准文号 | MedPath